1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 INTRODUCTION
2.2 SCOPE OF STUDY
2.3 RESEARCH OBJECTIVE
2.4 ASSUMPTIONS & LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
4 MARKET DYNAMICS
4.1 DRIVERS
4.1.1 EXTENSIVE R&D IN MEDICAL DEVICES
4.1.2 INCREASING GERIATRIC POPULATION IN EUROPE
4.1.3 INCREASED PREVALENCE SMOKING AND OTHER RESPIRATORY DISEASES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE APPLICATION OF RESPIRATORY THERAPEUTIC DEVICES AND TECHNOLOGY
5 MARKET FACTOR ANALYSIS
5.1 PORTERโS FIVE FORCES MODEL
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
6 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY DEVICES
6.1 NEBULIZERS
6.1.1 MECHANICAL NEBULIZER
6.1.1.1 SOFT MIST INHALER
6.1.1.2 HUMAN POWERED NEBULIZER
6.1.2 ELECTRICAL NEBULIZER
6.1.2.1 JET NEBULIZER
6.1.2.2 ULTRASONIC WAVE NEBULIZER
6.1.2.3 OTHER
6.2 HUMIDIFIERS
6.2.1 BUBBLE HUMIDIFIERS
6.2.2 ELECTRICAL HUMIDIFIER
6.3 OXYGEN CONCENTRATORS
6.3.1 CONTINUES OXYGEN CONCENTRATORS
6.3.2 PORTABLE OXYGEN CONCENTRATORS
6.4 VENTILATORS
6.4.1 VOLUME-CYCLED VENTILATORS.
6.4.2 PRESSURE-CYCLED VENTILATORS
6.4.3 FLOW-CYCLED VENTILATORS
6.4.4 OTHER
6.5 GAS ANALYZERS
6.6 CAPNOGRAPHS
6.7 POSITIVE AIRWAY PRESSURE (PAP)
6.7.1 CONTINUOUS POSITIVE AIRWAY PRESSURE
6.7.2 AUTOMATIC POSITIVE AIRWAY PRESSURE
6.7.3 OTHER
6.8 MASKS
6.8.1 NASAL MASK
6.8.2 FULL FACE MASK
6.8.3 OTHER
6.9 OTHERS
7 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY TECHNOLOGY
7.1 ELECTROSTATIC FILTRATION
7.2 HEPA FILTER
7.3 HOLLOW FIBER FILTRATION
7.4 MICROSPHERE SEPARATION
7.5 OTHERS
8 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY END USER
8.1 HOSPITAL
8.2 HOMECARE
9 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.1.1 ASIA
9.1.1.1 JAPAN
9.1.1.2 CHINA
9.1.1.3 INDIA
9.1.1.4 AUSTRALIA
9.1.1.5 REPUBLIC OF KOREA
9.1.1.5 REST OF ASIA-PACIFIC
10 COMPETITIVE LANDSCAPE
10.1 PRICING OF RESPIRATORY THERAPEUTIC DEVICES
10.2 PRODUCTION CAPACITY OF MAJOR PLAYERS
11 COMPANY PROFILE
11.1 MASIMO CORPORATION
11.1.1 OVERVIEW
11.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.1.3 FINANCIAL UPDATES
11.1.4 KEY DEVELOPMENTS
11.2 BECTON, DICKINSON AND COMPANY
11.2.1 OVERVIEW
11.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.2.3 FINANCIAL UPDATES
11.2.4 KEY DEVELOPMENTS
11.3 KONINKLIJKE PHILIPS
11.3.1 OVERVIEW
11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.3.3 FINANCIAL UPDATES
11.3.4 KEY DEVELOPMENTS
11.4 TERUMA MEDICAL CORPORATION
11.4.1 OVERVIEW
11.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.4.3 FINANCIAL UPDATES
11.4.4 KEY DEVELOPMENTS
11.5 HAMILTON MEDICAL AG
11.5.1 OVERVIEW
11.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.5.3 FINANCIAL UPDATES
11.5.4 KEY DEVELOPMENTS
11.6 PORTEX DIVISION OF SMITH INDUSTRIES MEDICAL SYSTEM
11.6.1 OVERVIEW
11.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.6.3 FINANCIAL UPDATES
11.6.4 KEY DEVELOPMENTS
11.7 OTHERS
12. BIBLIOGRAPHY